Persistence of antibodies to the topical hemostat bovine thrombin

Journal of the American College of Surgeons

Volumn 211, Issue 6, 2010, Pages 798-803

  Randleman Jr , C Duane ^a   Singla, Neil K ^b   Renkens, Kenneth L ^c   Souza, Sonia ^d   Pribble, John P ^d   Alexander, W Allan ^d  

^a Varicosity Vein Center   (United States)

^b HUNTINGTON MEMORIAL HOSPITAL   (United States)

^c INDIANA SPINE GROUP   (United States)

^d ZYMOGENETICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BOVINE THROMBIN ANTIBODY; THROMBIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; HUMAN; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TIME;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANIMALS; ANTIBODIES; CATTLE; CLINICAL TRIALS AS TOPIC; CONFIDENCE INTERVALS; FEMALE; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS; IMMUNIZATION; IMMUNOASSAY; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; THROMBIN; TIME FACTORS;

EID: 78649513276     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2010.07.023     Document Type: Article

References (27)

1. E.D. Warner, K.M. Brinkhous, and W.H. Seegers Further experience with the use of thrombin as a hemostatic agent Proc Soc Exper Biol Med 41 1939 655 657
2. J.H. Lawson The clinical use and immunologic impact of thrombin in surgery Semin Thromb Hemost 32 2006 98 110
3. King Pharmaceuticals, Inc January 14, 2008 Press Release http://www.kingpharm.com/Investors/News-Details.cfm?news-item-id=459 2008 Accessed August 11, 2010
4. R.L. Lundblad, R.A. Bradshaw, and D. Gabriel A review of the therapeutic uses of thrombin Thromb Haemost 91 2004 851 860 (Pubitemid 38647487)
5. D.L. Diesen, and J.H. Lawson Bovine thrombin: history, use, and risk in the surgical patient Vascular 16 2008 S29 S36
6. ®. 2007.
7. S.I. O'Shea, J.H. Lawson, and D. Reddan Hypercoagulable states and antithrombotic strategies in recurrent vascular access site thrombosis J Vasc Surg 38 2003 541 548
8. T.L. Ortel, K.D. Moore, and M.A. Quinn-Allen Inhibitory anti-factor V antibodies bind to the factor V C2 domain and are associated with hemorrhagic manifestations Blood 91 1998 4188 4196
9. Z. Su, T. Izumi, and E.H. Thames Antiphospholipid antibodies after surgical exposure to topical bovine thrombin J Lab Clin Med 139 2002 349 356
10. P. Ness, M. Creer, and G.M. Rodgers Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety Patient Saf Surg 3 2009 8
11. T.L. Ortel, M.C. Mercer, and E.H. Thames Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin Ann Surg 233 2001 88 96
12. N. Winterbottom, J.M. Kuo, and K. Nguyen Antigenic responses to bovine thrombin exposure during surgery: A prospective study of 309 patients J Applied Res 2 2002 1 11
13. W.C. Chapman, N. Singla, and Y. Genyk A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis J Am Coll Surg 205 2007 256 265
14. N.K. Singla, J.L. Ballard, and G. Moneta A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis J Am Coll Surg 209 2009 68 74
15. R.P. Dorion, H.F. Hamati, and B. Landis Risk and clinical significance of developing antibodies induced by topical thrombin preparations Arch Pathol Lab Med 122 1998 887 894
16. C. Doria, C.P. Fischer, and C.G. Wood Phase 3, randomized, double-blind study of plasma-derived human thrombin versus bovine thrombin in achieving hemostasis in patients undergoing surgery Curr Med Res Opin 24 2008 785 794
17. A. Terrab, D. Pawlak, and P. Spaay Further removal of factor V related antigen from bovine thrombin by utilizing a membrane-filtration step Clin Appl Thromb Hemost 14 2008 135 140
18. H. Zhu, D. Hoppensteadt, and R. Wahi Reduced immunogenic potential of membrane filtered bovine thrombin preparations for hemostatic application Clin Appl Thromb Hemost 15 2009 32 40
19. J.H. Lawson, K.A. Lynn, and R.M. Vanmatre Antihuman factor V antibodies after use of relatively pure bovine thrombin Ann Thorac Surg 79 2005 1037 1038
20. J.J. Naoum Immune-mediated coagulopathy: a case report Pharmacotherapy 29 2009 13S 17S
21. C.M. Cheng, C. Meyer-Massetti, and S.R. Kayser A review of three stand-alone topical thrombins for surgical hemostasis Clin Ther 31 2009 32 41
22. M.B. Streiff, and P.M. Ness Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure Transfusion 42 2002 18 26
23. D.G. Greenhalgh, R.L. Gamelli, and J. Collins Recombinant thrombin: safety and immunogenicity in burn wound excision and grafting J Burn Care Res 30 2009 371 379
24. A. Agresti, and B.A. Coull Approximate is better than exact for interval estimation of binomial proportions Am Stat 52 1998 119 126
25. C. Paterson, and J. Fareed Anti-human thrombin anti-bodies and factor V/Va antibodies in normal human subjects [abstract PP-M)-412] J Thromb Haemost 7 Suppl 2 2009 457
26. M. Resti, G. Di Francesco, and C. Azzari Anti-HBs and immunological memory to HBV vaccine: implication for booster timing Vaccine 11 1993 1079
27. D.J. West, and G.B. Calandra Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination Vaccine 14 1996 1019 1027